U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
RILZABRUTINIB
NWN58M4F5T
Investigational
General
Record Details
Names
7
Classification
2
Identifiers
6
Mixture Components
2
Relationships
1
Active Moiety
1
RILZABRUTINIB
NWN58M4F5T
Investigational
General
Approval Year
Unknown
139,594
Record Details
Substance Class
Mixture
Record UNII
NWN58M4F5T
Record Status
Validated (UNII)
Record Version
17
16
15
14
13
12
11
10
9
8
7
6
5
4
3
2
1
Names
7
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
RILZABRUTINIB
Official Name
English
(E/Z)-(R)-2-(3-(4-AMINO-3-(2-FLUORO-4-PHENOXYPHENYL)-1H-PYRAZOLO(3,4-D)PYRIMIDIN-1-YL)PIPERIDINE-1-CARBONYL)-4-METHYL-4-(4-(OXETAN-3-YL)PIPERAZIN-1-YL)PENT-2-ENENITRILE
Systematic Name
English
PRN-1008
Common Name
English
1-PIPERIDINEPROPANENITRILE, 3-(4-AMINO-3-(2-FLUORO-4-PHENOXYPHENYL)-1H-PYRAZOLO(3,4-D)PYRIMIDIN-1-YL)-.ALPHA.-(2-METHYL-2-(4-(3-OXETANYL)-1-PIPERAZINYL)PROPYLIDENE)-.BETA.-OXO-, (.ALPHA.E/Z,3R)-
Systematic Name
English
PRN1008
Code
English
Showing 1 to 5 of 7 entries
Previous
1
2
Next
Classification
2
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Designated/Withdrawn
ORPHAN DRUG
Designated/Withdrawn
Treatment of Pemphigus Vulgaris
FDA ORPHAN DRUG
582517
Designated
ORPHAN DRUG
Designated
Treatment of immune thrombocytopenic purpura (ITP)
FDA ORPHAN DRUG
605717
Showing 1 to 2 of 2 entries
Previous
1
Next
Identifiers
6
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
SMS_ID
100000177401
PRIMARY
INN
10966
PRIMARY
CAS
1575591-66-0
PRIMARY
USAN
HI-144
PRIMARY
NCI_THESAURUS
C174769
PRIMARY
Showing 1 to 5 of 6 entries
Previous
1
2
Next
Mixture Components
2
All of the following components
must
be present:
5G1WE425BI
RILZABRUTINIB, (E)-
0975516WHA
RILZABRUTINIB, (Z)-
Relationships
1
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
HG6WHF74KQ
TYROSINE-PROTEIN KINASE BTK C481F MUTANT
TARGET -> INHIBITOR
Comments:
PRN-1008 is a covalent, but reversible BTK inhibitor
Interaction Type:
BINDING
Qualification:
IC50
Amount:
RELATIONSHIP_AMOUNT 1.5 NANOMOLAR (average)
Showing 1 to 1 of 1 entries
Previous
1
Next
Active Moiety
1
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
NWN58M4F5T
RILZABRUTINIB
ACTIVE MOIETY
Showing 1 to 1 of 1 entries
Previous
1
Next
Definition References